Roca, N, Jatem, E, Abo, A, Santacana, M, Cruz, A, Madrid, A, Fraga, G, Martin, M, Gonzalez, J, Martinez, C, Balius, A, Segarra, A. CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab215. PMID:35211308. IF:4.600(Q1/2D).

Bataller, A, Garrido, A, Guijarro, F, Onate, G, Diaz-Beya, M, Arnan, M, Tormo, M, Vives, S, de Llano, MPQ, Coll, R, Gallardo, D, Vall-Llovera, F, Escoda, L, Garcia-Guinon, A, Salamero, O, Sampol, A, Merchan, BM, Bargay, J, Castano-Diez, S, Esteban, D, Oliver-Caldes, A, Rivero, A, Mozas, P, Lopez-Guerra, M, Pratcorona, M, Zamora, L, Costa, D, Rozman, M, Nomdedeu, JF, Colomer, D, Brunet, S, Sierra, J, Esteve, J. European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol. Blood Advances. 2022; 6(4)DOI:10.1182/bloodadvances.2021005585. PMID:34911079. IF:7.500(Q1/2D).

Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).

Malmusi, D, Pasarin, MI, Mari-Dell'Olmo, M, Artazcoz, L, Diez, E, Tolosa, S, Rodriguez-Sanz, M, Perez, G, Pena-Gallardo, C, Borrell, C. Multi-level policy responses to tackle socioeconomic inequalities in the incidence of COVID-19 in a European urban area. International Journal for Equity in Health. 2022; 21(1)DOI:10.1186/s12939-022-01628-1. PMID:35183189. IF:4.800(Q1/2D).